Global Epilepsy Drugs Market Research Report 2021

 Table of Contents


Global Epilepsy Drugs Market Research Report 2021
1 Epilepsy Drugs Overview
    1.1 Product Overview and Scope of Epilepsy Drugs
    1.2 Epilepsy Drugs Segment by Types
        1.2.1 Global Sales Market Share of Epilepsy Drugs by Type in 2015
        1.2.2 First-generation Anti-epileptic Drugs
        1.2.3 Second-generation Anti-epileptic Drugs
        1.2.4 Third-generation Anti-epileptic Drugs
    1.3 Epilepsy Drugs Segment by Applications
        1.3.1 Application 1
        1.3.2 Application 2
        1.3.3 Application 3
    1.4 Epilepsy Drugs Market by Regions
        1.4.1 North America Status and Prospect (2011-2021)
        1.4.2 China Status and Prospect (2011-2021)
        1.4.3 Europe Status and Prospect (2011-2021)
        1.4.4 Japan Status and Prospect (2011-2021)
        1.4.5 India Status and Prospect (2011-2021)
        1.4.6 Southeast Asia Status and Prospect (2011-2021)
    1.5 Global Market Size (Value and Volume) of Epilepsy Drugs (2011-2021)
        1.5.1 Global Epilepsy Drugs Sales and Revenue (2011-2021)
        1.5.2 Global Epilepsy Drugs Sales and Growth Rate (2011-2021)
        1.5.3 Global Epilepsy Drugs Revenue and Growth Rate (2011-2021)

2 Global Epilepsy Drugs Market Competition by Manufacturers
    2.1 Global Epilepsy Drugs Sales and Share by Manufacturers (2015 and 2016)
    2.2 Global Epilepsy Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Manufacturers Epilepsy Drugs Manufacturing Base Distribution and Product Type
    2.4 Competitive Situation and Trends
        2.4.1 Expansions
        2.4.2 New Product Launches
        2.4.3 Acquisitions
        2.4.4 Other Developments

3 Global Epilepsy Drugs Analysis by Region
    3.1 Global Epilepsy Drugs Sales, Revenue and Market Share by Region (2011-2021)
        3.1.1 Global Epilepsy Drugs Sales Market Share by Region (2011-2021)
        3.1.2 Global Epilepsy Drugs Revenue Market Share by Region (2011-2021)
    3.2 North America
        3.2.1 North America Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.2.2 North America Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
    3.3 Europe
        3.3.1 Europe Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.3.2 Europe Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
    3.4 China
        3.4.1 China Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.4.2 China Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
    3.5 Japan
        3.5.1 Japan Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.5.2 Japan Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
    3.6 India
        3.6.1 India Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.6.2 India Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
    3.7 Southeast Asia
        3.7.1 Southeast Asia Epilepsy Drugs Sales, Revenue and Price (2011-2021)
        3.7.2 Southeast Asia Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)

4 Global Epilepsy Drugs Analysis by Type
    4.1 Global Epilepsy Drugs Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
        4.1.1 Global Epilepsy Drugs Sales and Market Share by Type (2011-2021)
        4.1.2 Global Epilepsy Drugs Revenue, Market Share and Growth Rate by Type (2011-2021)
    4.2 First-generation Anti-epileptic Drugs Sales, Revenue, Price and Growth (2011-2021)
    4.3 Second-generation Anti-epileptic Drugs Sales, Revenue, Price and Growth (2011-2021)
    4.4 Third-generation Anti-epileptic Drugs Sales, Revenue, Price and Growth (2011-2021)

5 Global Epilepsy Drugs Market Analysis by Application
    5.1 Global Epilepsy Drugs Sales and Market Share by Application (2011-2021)
    5.2 Major Regions Epilepsy Drugs Sales by Application in 2015 and 2016
        5.2.1 North America Epilepsy Drugs Sales by Application
        5.2.2 Europe Epilepsy Drugs Sales by Application
        5.2.3 China Epilepsy Drugs Sales by Application
        5.2.4 Japan Epilepsy Drugs Sales by Application
        5.2.5 India Epilepsy Drugs Sales by Application
        5.2.6 Southeast Asia Epilepsy Drugs Sales by Application

6 Global Epilepsy Drugs Manufacturers Analysis
    6.1 Eisai
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Epilepsy Drugs Product Overview
            6.1.2.1 First-generation Anti-epileptic Drugs
            6.1.2.2 Second-generation Anti-epileptic Drugs
            6.1.2.3 Third-generation Anti-epileptic Drugs
        6.1.3 Epilepsy Drugs Sales, Revenue, Price of Eisai (2015 and 2016)
    6.2 GSK
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Epilepsy Drugs Product Overview
            6.2.2.1 First-generation Anti-epileptic Drugs
            6.2.2.2 Second-generation Anti-epileptic Drugs
            6.2.2.3 Third-generation Anti-epileptic Drugs
        6.2.3 Epilepsy Drugs Sales, Revenue, Price of GSK (2015 and 2016)
    6.3 Pfizer
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Epilepsy Drugs Product Overview
            6.3.2.1 First-generation Anti-epileptic Drugs
            6.3.2.2 Second-generation Anti-epileptic Drugs
            6.3.2.3 Third-generation Anti-epileptic Drugs
        6.3.3 Epilepsy Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)
    6.4 UCB
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Epilepsy Drugs Product Overview
            6.4.2.1 First-generation Anti-epileptic Drugs
            6.4.2.2 Second-generation Anti-epileptic Drugs
        6.4.3 Epilepsy Drugs Sales, Revenue, Price of UCB (2015 and 2016)
    6.5 AbbVie
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Epilepsy Drugs Product Overview
            6.5.2.1 First-generation Anti-epileptic Drugs
            6.5.2.2 Second-generation Anti-epileptic Drugs
        6.5.3 Epilepsy Drugs Sales, Revenue, Price of AbbVie (2015 and 2016)
    6.6 Acorda Therapeutics
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Epilepsy Drugs Product Overview
            6.6.2.1 First-generation Anti-epileptic Drugs
            6.6.2.2 Second-generation Anti-epileptic Drugs
        6.6.3 Epilepsy Drugs Sales, Revenue, Price of Acorda Therapeutics (2015 and 2016)
    6.7 Alexza Pharmaceuticals
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Epilepsy Drugs Product Overview
            6.7.2.1 First-generation Anti-epileptic Drugs
            6.7.2.2 Second-generation Anti-epileptic Drugs
        6.7.3 Epilepsy Drugs Sales, Revenue, Price of Alexza Pharmaceuticals (2015 and 2016)
    6.8 Aprecia Pharmaceuticals
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Epilepsy Drugs Product Overview
            6.8.2.1 First-generation Anti-epileptic Drugs
            6.8.2.2 Second-generation Anti-epileptic Drugs
        6.8.3 Epilepsy Drugs Sales, Revenue, Price of Aprecia Pharmaceuticals (2015 and 2016)
    6.9 Aurobindo Pharma
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Epilepsy Drugs Product Overview
            6.9.2.1 First-generation Anti-epileptic Drugs
            6.9.2.2 Second-generation Anti-epileptic Drugs
        6.9.3 Epilepsy Drugs Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
    6.10 Biscayne Pharmaceuticals
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Epilepsy Drugs Product Overview
            6.10.2.1 First-generation Anti-epileptic Drugs
            6.10.2.2 Second-generation Anti-epileptic Drugs
        6.10.3 Epilepsy Drugs Sales, Revenue, Price of Biscayne Pharmaceuticals (2015 and 2016)
    6.11 CURx Pharmaceuticals
    6.12 Dainippon Sumitomo Pharma
    6.13 D-Pharm
    6.14 F. Hoffmann-La Roche
    6.15 Grupo Ferrer Internacional
    6.16 GW Pharmaceuticals
    6.17 Insero Health
    6.18 INSYS Therapeutics
    6.19 Janssen Pharmaceuticals
    6.20 Ligand Pharmaceuticals
    6.21 H. Lundbeck
    6.22 MarcoPolo Pharmaceuticals
    6.23 Marinus Pharmaceuticals
    6.24 Meda
    6.25 Neurelis
    6.26 Nobelpharma
    6.27 Novartis
    6.28 Orphelia Pharma
    6.29 SAGE Therapeutics
    6.30 SciFlour

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures


Figure Picture of Epilepsy Drugs
Figure Global Sales Market Share of Epilepsy Drugs by Type in 2015
Table Epilepsy Drugs Product Type of by Manufacturers
Table Epilepsy Drugs Sales Market Share by Application in 2015 and 2016
Figure North America Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Figure China Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Figure Japan Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Figure India Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Table Global Epilepsy Drugs Sales and Revenue (2011-2021)
Figure Global Epilepsy Drugs Sales and Growth Rate (2011-2021)
Figure Global Epilepsy Drugs Revenue and Growth Rate (2011-2021)
Table Global Epilepsy Drugs Sales of Key Manufacturers (2015 and 2016)
Table Global Epilepsy Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Epilepsy Drugs Sales Share by Manufacturers
Figure 2016 Epilepsy Drugs Sales Share by Manufacturers
Table Global Epilepsy Drugs Revenue by Manufacturers (2015 and 2016)
Table Global Epilepsy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Epilepsy Drugs Revenue Share by Manufacturers
Table 2016 Global Epilepsy Drugs Revenue Share by Manufacturers
Table Manufacturers Epilepsy Drugs Manufacturing Base Distribution and Product Type
Table Global Epilepsy Drugs Sales Market by Region (2011-2021)
Figure Global Epilepsy Drugs Sales Market by Region (2011-2021)
Figure Global Epilepsy Drugs Sales Market Share by Region (2011-2021)
Table Global Epilepsy Drugs Revenue Market by Region (2011-2021)
Table Global Epilepsy Drugs Revenue Market Share by Region (2011-2021)
Table North America Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure North America Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Europe Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure Europe Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
Table China Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure China Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Japan Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure Japan Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
Table India Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure India Epilepsy Drugs Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Epilepsy Drugs Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Epilepsy Drugs Sales, Revenue and Growth Rate  (2011-2021)
Table Global Epilepsy Drugs Sales by Type (2011-2021)
Table Global Epilepsy Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Epilepsy Drugs by Type (2011-2021)
Figure Global Epilepsy Drugs Sales Growth Rate by Type (2011-2021)
Table Global Epilepsy Drugs Revenue by Type (2011-2021)
Table Global Epilepsy Drugs Revenue Share by Type (2011-2021)
Figure Global Epilepsy Drugs Revenue Growth Rate by Type (2011-2021)
Figure First-generation Anti-epileptic Drugs Sales, Revenue and Growth (2011-2021)
Figure First-generation Anti-epileptic Drugs Price Trend (2011-2021)
Figure Second-generation Anti-epileptic Drugs Sales, Revenue and Growth (2011-2021)
Figure Second-generation Anti-epileptic Drugs Price Trend (2011-2021)
Figure Third-generation Anti-epileptic Drugs Sales, Revenue and Growth (2011-2021)
Figure Third-generation Anti-epileptic Drugs Price Trend (2011-2021)
Table Global Epilepsy Drugs Sales by Application (2011-2021)
Table Global Epilepsy Drugs Sales Market Share by Application (2011-2021)
Figure Global Epilepsy Drugs Sales Market Share by Application in 2015
Figure Global Epilepsy Drugs Sales Market Share by Application in 2021
Table North America Epilepsy Drugs Sales by Application (2015 and 2016)
Table Europe Epilepsy Drugs Sales by Application (2015 and 2016)
Table China Epilepsy Drugs Sales by Application (2015 and 2016)
Table Japan Epilepsy Drugs Sales by Application (2015 and 2016)
Table India Epilepsy Drugs Sales by Application (2015 and 2016)
Table Southeast Asia Epilepsy Drugs Sales by Application (2015 and 2016)
Table Global Epilepsy Drugs Sales Growth Rate by Application (2011-2021)
Figure Global Epilepsy Drugs Sales Growth Rate by Application (2011-2021)
Table Eisai Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Eisai (2015 and 2016)
Table GSK Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of GSK (2015 and 2016)
Table Pfizer Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Pfizer (2015 and 2016)
Table UCB Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of UCB (2015 and 2016)
Table AbbVie Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of AbbVie (2015 and 2016)
Table Acorda Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Acorda Therapeutics (2015 and 2016)
Table Alexza Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Alexza Pharmaceuticals (2015 and 2016)
Table Aprecia Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Aprecia Pharmaceuticals (2015 and 2016)
Table Aurobindo Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Aurobindo Pharma (2015 and 2016)
Table Biscayne Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Biscayne Pharmaceuticals (2015 and 2016)
Table CURx Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of CURx Pharmaceuticals (2015 and 2016)
Table Dainippon Sumitomo Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Dainippon Sumitomo Pharma (2015 and 2016)
Table D-Pharm Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of D-Pharm (2015 and 2016)
Table F. Hoffmann-La Roche Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Grupo Ferrer Internacional Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Grupo Ferrer Internacional (2015 and 2016)
Table GW Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of GW Pharmaceuticals (2015 and 2016)
Table Insero Health Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Insero Health (2015 and 2016)
Table INSYS Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of INSYS Therapeutics (2015 and 2016)
Table Janssen Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Janssen Pharmaceuticals (2015 and 2016)
Table Ligand Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Ligand Pharmaceuticals (2015 and 2016)
Table H. Lundbeck Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of H. Lundbeck (2015 and 2016)
Table MarcoPolo Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of MarcoPolo Pharmaceuticals (2015 and 2016)
Table Marinus Pharmaceuticals Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Marinus Pharmaceuticals (2015 and 2016)
Table Meda Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Meda (2015 and 2016)
Table Neurelis Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Neurelis (2015 and 2016)
Table Nobelpharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Nobelpharma (2015 and 2016)
Table Novartis Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
Table Orphelia Pharma Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of Orphelia Pharma (2015 and 2016)
Table SAGE Therapeutics Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of SAGE Therapeutics (2015 and 2016)
Table SciFlour Basic Information List
Table Epilepsy Drugs Sales, Revenue, Price of SciFlour (2015 and 2016)
 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy